You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Colorcon
Merck
McKinsey
Johnson and Johnson

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

MEMANTINE HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Memantine Hydrochloride, and when can generic versions of Memantine Hydrochloride launch?

Memantine Hydrochloride is a drug marketed by Amneal Pharms, Anchen Pharms, Ani Pharms Inc, Apotex, Lupin Ltd, Mylan, Sun Pharm, Zydus Pharms, Lannett Co Inc, Macleods Pharms Ltd, Torrent, Ajanta Pharma Ltd, Alembic Pharms Ltd, Aurobindo Pharma Ltd, Cadila, Celltrion, Chartwell, Cspc Ouyi, Dr Reddys Labs Ltd, Hikma, Jubilant Generics, Ningbo, Orchid Hlthcare, Puracap Pharm Llc, Strides Pharma, Teva Pharms, Unichem Labs Ltd, and Upsher Smith Labs. and is included in thirty-seven NDAs.

The generic ingredient in MEMANTINE HYDROCHLORIDE is donepezil hydrochloride; memantine hydrochloride. There are thirty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride; memantine hydrochloride profile page.

Drug patent expirations by year for MEMANTINE HYDROCHLORIDE
Recent Clinical Trials for MEMANTINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicEarly Phase 1
National Cancer Institute (NCI)Early Phase 1
Zealand University HospitalPhase 4

See all MEMANTINE HYDROCHLORIDE clinical trials

Pharmacology for MEMANTINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for MEMANTINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for MEMANTINE HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
NAMENDA XR CAPSULE, EXTENDED RELEASE;ORAL memantine hydrochloride 022525 2013-06-10
NAMENDA TABLET;ORAL memantine hydrochloride 021487 2007-10-16

US Patents and Regulatory Information for MEMANTINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Puracap Pharm Llc MEMANTINE HYDROCHLORIDE memantine hydrochloride TABLET;ORAL 206855-002 Nov 17, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms MEMANTINE HYDROCHLORIDE memantine hydrochloride TABLET;ORAL 090041-001 Apr 10, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Zydus Pharms MEMANTINE HYDROCHLORIDE memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 203293-004 Aug 3, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 208328-002 Jan 27, 2017 DISCN No No   Start Trial   Start Trial   Start Trial
Chartwell MEMANTINE HYDROCHLORIDE memantine hydrochloride TABLET;ORAL 090244-001 Jul 11, 2018 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Moodys
McKesson
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.